The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic

J Med Toxicol. 2020 Jul;16(3):311-313. doi: 10.1007/s13181-020-00786-4. Epub 2020 May 27.

Authors

Erin R Fox¹, Andrew I Stolbach², Maryann Mazer-Amirshahi^{3

4}

Affiliations

¹ Department of Pharmacy, University of Utah Health, Salt Lake City, UT, USA.
² Johns Hopkins School of Medicine, Baltimore, MD, USA.
³ Department of Emergency Medicine, MedStar Washington Hospital Center, 110 Irving St NW, Washington, DC, 20010, USA. maryannmazer@gmail.com.
⁴ Georgetown University School of Medicine, Washington, DC, USA. maryannmazer@gmail.com.

No abstract available

Keywords: COVID-19 pandemic; Prescription drug shortages.

MeSH terms

Antiviral Agents / supply & distribution*
Antiviral Agents / therapeutic use*
Betacoronavirus / drug effects
COVID-19
Coronavirus Infections / drug therapy*
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Prescription Drugs / supply & distribution*
Prescription Drugs / therapeutic use*
SARS-CoV-2

Substances

Antiviral Agents
Prescription Drugs